Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113735826A details a novel Pd-catalyzed carbonylation route for 3-benzylidene-2,3-dihydroquinolones, offering safer CO surrogates and high yields for pharmaceutical intermediates.
Novel iodine-catalyzed oxidative spirocyclization for high-purity pharmaceutical intermediates. Cost-effective, scalable, and environmentally friendly manufacturing solution.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis for high-purity antitumor intermediates, offering significant cost reduction and supply reliability.
Novel patent CN104447355A offers high-purity Bromhexine Hydrochloride synthesis. Safe scalable route for reliable pharmaceutical intermediates supplier.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones. High yield, scalable process for API intermediates reducing manufacturing complexity.
Patent CN115353511A details a mild, multi-component synthesis route for carbonyl-bridged biheterocycles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116640146A reveals an efficient Pd-catalyzed route for trifluoromethyl chromonoquinoline. This innovation offers significant cost reduction and scalable supply chain reliability for high-purity pharmaceutical intermediates globally.
Efficient carbonylation method for N-aryl amides using aryl boronic acids. Reduces harsh conditions, offering cost-effective manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation patent CN113735826B offers efficient pharmaceutical intermediate manufacturing with scalable cost reduction and supply chain reliability.
Patent CN104945339B reveals efficient one-pot synthesis. Delivers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Novel patent CN115403520B offers efficient quinolin-2(1H)-one synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-purity pharmaceutical intermediates with scalable production capabilities and significant cost reduction for global supply chains demanding reliable API intermediate sources.
Patent CN116253697B reveals a base-promoted one-pot synthesis for quinone thiazoles. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN110467555A reveals chiral phosphoric acid catalysis for high-purity axial chiral arylindole compounds, offering cost reduction and supply chain reliability.
Patent CN111423381B details a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering cost-effective supply chain solutions for API manufacturing.
Patent CN106467481B enables visible-light synthesis of indole ketones without transition metals, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Novel Pd-catalyzed one-pot synthesis for trifluoromethyl chromonoquinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Advanced synthesis of chiral six-membered NHC precursor salts offering enhanced stability and catalytic efficiency for pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable API intermediate manufacturing.
Novel Pd-catalyzed dearomatization route for indolinotetrahydropyran compounds. High yield, mild conditions, scalable for anti-tumor drug development.